CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06488378
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:24.900887+00:00
- Published At
- 2025-08-22T00:00:00+00:00
- Record Updated At
- 2025-08-22
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Breast Cancer", "PALB2-Mutated Breast Carcinoma", "HER2-negative Breast Cancer", "BRCA1 Mutation", "BRCA2 Mutation"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-08-22"- protocolSection.identificationModule.nctId
"NCT06488378"- protocolSection.identificationModule.officialTitle
"Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.